• untorquer@lemmy.world
    link
    fedilink
    English
    arrow-up
    2
    ·
    11 hours ago

    My only wild and reaching guess, beyond simple cruelty and hatred, is marketing was afraid of associating the drug with periods because “men would get grossed out” and potentially impact that share of the market.

    • squaresinger@lemmy.world
      link
      fedilink
      English
      arrow-up
      2
      ·
      11 hours ago

      Probably something like that… Sucks.

      And it’s kinda stupid too. PMS is well known to not be conductive to female libido, and female libido is conductive to Viagra sales. So why not sell it to women too (=more sales) which might increase the occasions to sell it to men as well.

      • untorquer@lemmy.world
        link
        fedilink
        English
        arrow-up
        1
        ·
        10 hours ago

        IDK if i have a partner i want them to be comfortable. Idk whether there’s just a lot of incels in powerful places or men have historically just hated the women they’re with. Either way that’s one reason I don’t identify as a man.

        • squaresinger@lemmy.world
          link
          fedilink
          English
          arrow-up
          1
          ·
          edit-2
          7 hours ago

          I wonder if actually helpful PMS medication would cannibalize e.g. pain medication sales. Generic viagra is super cheap, and in the study they used just one dose. So if that’s the actual dosage required in the end, that could cost the pharmaceuticals industry money.

          Similar to with vas occlusive contraception. It’s really easy, simple, dirt cheap, lasts long, is reversible, non-hormonal, no side effects male contraception. It’s basically the perfect contraception and it’s the only reversible long-term contraception that men can use.

          But it was dropped because it would pretty much annihilate the female contraceptive industry, which makes a huge amount of money each year.

          Quote from the Wiki article on RISUG, the form of Vas-occlusive contraception that came closest to getting to market:

          Despite this, pharmaceutical companies are reluctant to lose market share of a thriving global market for female contraceptives and condoms which bring billions of dollars of revenue each year. Initially, RISUG attracted some interest from pharmaceutical companies. However, considering that RISUG is an inexpensive, one-time procedure, manufacturers retracted.

          https://en.wikipedia.org/wiki/Reversible_inhibition_of_sperm_under_guidance

          • untorquer@lemmy.world
            link
            fedilink
            English
            arrow-up
            2
            ·
            5 hours ago

            Yeah i generally assume decisions like these are profit/hate driven. If you can make a market case, even mildly convincing that profits will be hit, it’s going to be researched enough to get copyright and bury as long as possible.

            Just can’t imagine being one of those researchers(if they knew/weren’t duped), board members or marketing fucks going home to someone who thinks they’re loved, watching them writhe in pain, and think, “yeah I’m gonna be so rich!”